Company intelligence
Lumos Diagnostics
Lumos (ASX:LDX) develops, manufactures and commercializes custom, rapid point-of-care diagnostic technologies
About Lumos Diagnostics
Lumos Diagnostics (ASX:LDX) specializes in rapid, cost-effective and complete point-of-care (POC) diagnostic test technology to help healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers customized assay development and manufacturing services for POC tests and proprietary digital reader platforms. Lumos also directly develops, manufactures and commercializes novel Lumos-branded POC tests that target infectious and inflammatory diseases.
Verified activity
Signals from Lumos Diagnostics
3 published signals
Presence & Recognition
Lumos Diagnostics is attending the Texas Nurse Practitioners Annual Conference in Galveston, Texas from September 24 to 27.
Reported by Lumos Diagnostics
Presence & Recognition
Lumos Diagnostics is attending the Texas Nurse Practitioners Annual Conference in Galveston from September 24 to 27.
Reported by Amelia Sirianni
Presence & Recognition
Lumos Diagnostics participated in a webinar with the Dallas-Fort Worth Hospital Council discussing FebriDx® for acute respiratory infections.
Reported by Lumos Diagnostics